$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Aster koraiensis extract prevents diabetes-induced retinal vascular dysfunction in spontaneously diabetic Torii rats 원문보기

Bmc complementary and alternative medicine, v.17, 2017년, pp.497 -   

Kim, Junghyun (Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yusengdae-ro, Daejeon, 34054 South Korea) ,  Jo, Kyuhyung (Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yusengdae-ro, Daejeon, 34054 South Korea) ,  Kim, Chan-Sik (Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yusengdae-ro, Daejeon, 34054 South Korea) ,  Kim, Jin Sook (Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yusengdae-ro, Daejeon, 34054 South Korea)

Abstract AI-Helper 아이콘AI-Helper

BackgroundAster koraiensis extract (AKE) is a standard dietary herbal supplement. The aim of this study is to investigate the inhibitory effects of AKE on diabetes-induced retinal vascular dysfunction in Spontaneously Diabetic Torii (SDT) rats.MethodsAKE (50 and 100 mg/kg body weight/day) was admini...

주제어

참고문헌 (26)

  1. 1. Fong DS Sharza M Chen W Paschal JF Ariyasu RG Lee PP Vision loss among diabetics in a group model health maintenance organization (HMO) Am J Ophthalmol 2002 133 2 236 241 10.1016/S0002-9394(01)01364-2 11812428 

  2. 2. Ciulla TA Amador AG Zinman B Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies Diabetes Care 2003 26 9 2653 2664 10.2337/diacare.26.9.2653 12941734 

  3. 3. Mehta D Malik AB Signaling mechanisms regulating endothelial permeability Physioligical Rev 2006 86 1 279 367 10.1152/physrev.00012.2005 

  4. 4. Harhaj NS Antonetti DA Regulation of tight junctions and loss of barrier function in pathophysiology Int J Biochem Cell Biol 2004 36 7 1206 1237 10.1016/j.biocel.2003.08.007 15109567 

  5. 5. Barber AJ A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog Neuro Psychopharmacol Biol Psychiat 2003 27 2 283 290 10.1016/S0278-5846(03)00023-X 

  6. 6. Girach A Manner D Porta M Diabetic microvascular complications: can patients at risk be identified? A review Int J Clin Pract 2006 60 11 1471 1483 10.1111/j.1742-1241.2006.01175.x 17073842 

  7. 7. Ahn DK Illustrated book of Korean medicinal herbs 1998 Seoul Kyo-Hak Publishing 

  8. 8. Ko JY Lee KK Effect of plant growth regulators on growth and flowering of potted Lychnis cognata, Aster koraiensis , and Campanula takesimana RDA J Agric Sci 1996 38 627 632 

  9. 9. Kim J, Jo K, Lee IS, Kim CS, Kim JS. The extract of Aster Koraiensis prevents retinal Pericyte apoptosis in diabetic rats and its active compound, Chlorogenic acid inhibits AGE formation and AGE/RAGE interaction. Nutrients. 2016;8(9):585. 

  10. 10. Lee J Lee YM Lee BW Kim JH Kim JS Chemical constituents from the aerial parts of Aster Koraiensis with protein glycation and aldose reductase inhibitory activities J Nat Prod 2012 75 2 267 270 10.1021/np200646e 22264115 

  11. 11. Sohn E Kim J Kim CS Kim YS Jang DS Kim JS Extract of the aerial parts of Aster Koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats Biochem Biophys Re Commun 2010 391 1 733 738 10.1016/j.bbrc.2009.11.129 

  12. 12. Qi W Zhao T Yang W-W Wang G-H Yu H Zhao H-X Yang C Sun L-X Comparative pharmacokinetics of chlorogenic acid after oral administration in rats J Pharml Anal 2011 1 4 270 274 10.1016/j.jpha.2011.09.006 

  13. 13. Sasase T Ohta T Ogawa N Miyajima K Ito M Yamamoto H Morinaga H Matsushita M Preventive effects of glycaemic control on ocular complications of spontaneously diabetic Torii rat Diab Obes Metab 2006 8 5 501 507 10.1111/j.1463-1326.2005.00535.x 

  14. 14. Masuyama T Komeda K Hara A Noda M Shinohara M Oikawa T Kanazawa Y Taniguchi K Chronological characterization of diabetes development in male spontaneously diabetic Torii rats Biochem Biophys Res Commun 2004 314 3 870 877 10.1016/j.bbrc.2003.12.180 14741717 

  15. 15. Shinohara M Masuyama T Shoda T Takahashi T Katsuda Y Komeda K Kuroki M Kakehashi A Kanazawa Y A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications Int J Exp Diabetes Res 2000 1 2 89 100 10.1155/EDR.2000.89 11469401 

  16. 16. Navaratna D McGuire PG Menicucci G Das A Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes Diabetes 2007 56 9 2380 2387 10.2337/db06-1694 17536065 

  17. 17. Watson PM Anderson JM Vanltallie CM Doctrow SR The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers Neurosci Lett 1991 129 1 6 10 10.1016/0304-3940(91)90708-2 1922971 

  18. 18. Hawkins BT Davis TP The blood-brain barrier/neurovascular unit in health and disease Pharmacol Rev 2005 57 2 173 185 10.1124/pr.57.2.4 15914466 

  19. 19. Koga K Yamagishi S Okamoto T Inagaki Y Amano S Takeuchi M Makita Z Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction Int J Clin Pharmacol Res 2002 22 1 13 17 12395914 

  20. 20. Miura J Yamagishi S Uchigata Y Takeuchi M Yamamoto H Makita Z Iwamoto Y Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes J Diabetes Complicat 2003 17 1 16 21 10.1016/S1056-8727(02)00183-6 12505751 

  21. 21. Stitt AW Bhaduri T McMullen CB Gardiner TA Archer DB Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats Mol Cell Biol Res Commun : MCBRC 2000 3 6 380 388 10.1006/mcbr.2000.0243 11032761 

  22. 22. Kasper M Roehlecke C Witt M Fehrenbach H Hofer A Miyata T Weigert C Funk RH Schleicher ED Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132 Am J Respir Cell Mol Biol 2000 23 4 485 491 10.1165/ajrcmb.23.4.4117 11017913 

  23. 23. Kaji Y Amano S Usui T Oshika T Yamashiro K Ishida S Suzuki K Tanaka S Adamis AP Nagai R Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells Investig Ophthalmol Vis Sci 2003 44 2 521 528 10.1167/iovs.02-0268 12556378 

  24. 24. Yamagishi S Inagaki Y Amano S Okamoto T Takeuchi M Makita Z Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochem Biophys Res Commun 2002 296 4 877 882 10.1016/S0006-291X(02)00940-3 12200129 

  25. 25. Kern TS Engerman RL Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin Diabetes 2001 50 7 1636 1642 10.2337/diabetes.50.7.1636 11423486 

  26. 26. Kim J Jeong IH Kim CS Lee YM Kim JM Kim JS Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking Arch Pharm Res 2011 34 3 495 500 10.1007/s12272-011-0319-5 21547683 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로